Curaleaf Holdings CEO Joseph Lusardi is ecstatic about the company’s record-setting, $400 million USD equity raise and recent listing on the CSE. Curaleaf operates in the United States, is a fully vertical medical cannabis operator, and sells 90 percent of what the company cultivates and produces in its dispensaries. The company will be operating in 12 states by the end of 2018 and is licensed to open 69 dispensaries nation-wide. Curaleaf’s largest footprint is in Florida, where it already has a strong delivery presence and 13 dispensaries, with plans to open 22 more stores in the coming months. Lusardi supports the STATES Act because it would open up banking and debt markets to US cannabis companies.
Sign up for our daily Newsletter and stay up to date with all the latest news!
Subscribe I am already a subscriber